NCT06760923Recruiting
Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression
Source: ClinicalTrials.gov · Last updated 7 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to determine the urinary proteomic characteristics in women with and without ovarian cancer. The main questions it aims to answer are: 1. What is the difference in urinary protein composition between patients with ovarian cancer and those without it? 2. Can these differences in urinary protein composition aid in the diagnosis of ovarian cancer? 3. Are urinary protein markers associated with tumor burden in urine samples from patients with ovarian cancer? 4. Can urinary protein markers be used for disease surveillance in ovarian cancer patients?
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 240 (estimated)
- First submitted
- 27 Dec 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Xiangya Hospital of Central South University
- Diseases
- Ovarian cancer
- NCT number
- NCT06760923
What you commit to
- Study type: Observational
- Planned participants: 240
- From 1 Jan 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Study participants with prior chronic kidney disease or renal insufficiency.
- Study participants who have received or are receiving treatment for primary disease.
Other illness
- Study participants with a prior history of malignant tumors.
Other
- Study participants whose pathological diagnosis was not clear.
- Any patient should be excluded from the study if:
- Study participants withdraw informed consent and request withdrawal.
- Study participants were unable to provide a qualified urine sample.
- There are situations in which the researcher considers it necessary to withdraw from the study.
Who the study is looking for
- Female patients in the gynecological ward for surgical treatment.
- Initial diagnosis of "pelvic mass" or "malignant ascites" may be considered as ovarian cancer; Or the initial diagnosis of "ovarian cyst", "hydrosalpinx", "uterine fibroids" or "uterine adenomyosis" are considered as gynecological non-malignant diseases.
- Over 18 years of age.
- Voluntary participation and signing of informed consent.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Xiangya Hosipital of Central South University Coordinator of this site? Confirm its status | Changsha | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.